Michael Bookman, GENERAL COUNSEL AND SECRETARY at Immuneering Corp (IMRX), bought 1,000 shares at $4.88 ($5K) on 2022-05-17, disclosed to the SEC on 2022-05-18.
Open-market purchase of $5k IMRX by GENERAL COUNSEL AND SECRETARY. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |